Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
As a multifactorial and multiorgan syndrome, cancer cachexia is associated with decreased tolerance to antitumor treatments and increased morbidity and mortality rates. The current approaches for the treatment of this syndrome are not always effective and well established. Drug repurposing or reposi...
Enregistré dans:
Auteurs principaux: | Joana M. O. Santos, Alexandra C. Costa, Tânia R. Dias, Setareh Satari, Maria Paula Costa e Silva, Rui M. Gil da Costa, Rui Medeiros |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f6d4ed0b4f014da6a9ec9e7f517439e8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks
par: Mapopa Chipofya, et autres
Publié: (2021) -
Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study
par: Angela Bonaccorso, et autres
Publié: (2021) -
Drug repurposing for tooth regeneration: The promising premises
par: T C Divya, et autres
Publié: (2021) -
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
par: Joelle C. Boulos, et autres
Publié: (2021) -
A 5 year retrospective analysis of adverse drug reactions associated with antimicrobials in a teaching hospital of Andaman and Nicobar islands
par: Mangesh Bankar, et autres
Publié: (2021)